Testing Urine for HPV to Screen for Cervical Cancer in Women With HIV
Checks whether urine samples can detect cervical cancer risk in women living with HIV.
Key facts
- Who runs it
- UNC Lineberger Comprehensive Cancer Center
- Where
- Westdene, South AfricaSee the site
- Trial code
- Registry title
- Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 11 May 2023
- Expected to end
- Aug 2027
- Type of study
- Interventional
- Treatments tested
- Urine HPV testing
- Self-collected cervicovaginal specimen
- Provider-collected cervical samples
- Record updated
- 30 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women living with HIV-1 who are 25 or older. It tests whether urine samples can be used to screen for cervical cancer.
- Age
- 25 years and older
- Sex
- Women only
- Earlier treatment
- Cannot have been screened for cervical cancer in the past year (365 days). Cannot have had an HPV vaccine.
- Biomarker or test result
- Confirmed HIV-1 infection
Main reasons for not taking part
- Pregnant, or planning to become pregnant within 90 days of enrollment
- Screened for cervical cancer within the past year (365 days)
- Active sexually transmitted infection (can join once treated)
- Cervix removed by surgery
- History of cervical cancer
This trial only enrols participants living with HIV. The registry sentence this rests on: Confirmed HIV-1 infection
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- In order to participate in this study a subject must meet all of the eligibility criteria outlined below
- Confirmed HIV-1 infection
- Age 25 years and older
- Be willing and able to provide written informed consent
Who cannot take part
- Have been screened for cervical cancer within the preceding year (365 days)
- Have an active sexually transmitted infection (STI; women may participate once treated)
- Have a history of cervical cancer
- Pregnant or intend to become pregnant within 90 days of enrollment
- Have a surgically absent cervix
- have been vaccinated against HPV
This trial is currently available in South Africa.
- Clinical HIV Research Unit Temba Lethu Wing Helen Joseph HospitalWestdene, South AfricaContact: Sibusisiwe LuvunoTaking people
About the trial
What the trial wants to find out
The purpose of this study explores the usefulness of urine samples for cervical cancer screening in human immunodeficiency virus (HIV)-infected women.
Read full original descriptionShow less
Cervical cancer occurs when women are infected with the human papillomavirus (HPV), which can cause changes in the cells that lead to cervical precancer and, eventually, cervical cancer if untreated. However, urine HPV testing has not been well validated low- and middle-income country settings, with no data available to guide its use in HIV-infected women.
The group in the trial
- Single ArmOther group
This is a single arm study. All participants will receive same interventions.
Treatment: Urine HPV testing, Self-collected cervicovaginal specimen, and Provider-collected cervical samples
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Performance Validation of Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa
- Plain-language title
- Testing Urine for HPV to Screen for Cervical Cancer in Women With HIVGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 30 September 2026